Karen E. Pollok

Medicine · Indiana University

Sarcoma Diagnosis and Treatment Neuroblastoma Research and Treatments Neurofibromatosis and Schwannoma Cases Virus-based gene therapy research Glioma Diagnosis and Treatment

Publications

355

Citations

7,400

Est. group size

Recurring co-author estimate

Active years

Publishing since 1989

Research summary

AI-generated

Karen E. Pollok researches cancer treatments, with a focus on childhood and rare cancers such as sarcomas and neuroblastoma, as well as brain tumors like glioblastoma. Her work includes developing new drug-delivery methods (for example, nanoparticles that target cancer stem cells) and exploring gene therapy and precision medicine approaches. Much of this involves laboratory testing of novel therapeutics to overcome tumor resistance.

Pediatric and rare childhood cancersGlioblastoma and brain tumor therapyTargeted drug delivery and nanoparticlesCancer stem cell resistancePrecision medicine and gene therapy

Publication activity has generally grown over the past decade, with notably high output in recent years (2023 and 2025).

Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026

Publication cadence

Publications per year over the last 10 years — averaging 28.6/year recently

Recent publications

Fighting for the Few: Advancing Research in Rare Childhood Cancers
ENGAGE! · 2026
Novel Therapeutics and drug-delivery Approaches in the Modulation of Glioblastoma Stem Cell Resistance
Therapeutic Delivery · 2022
Development of CD133 Targeting Multi-Drug Polymer Micellar Nanoparticles for Glioblastoma - In Vitro Evaluation in Glioblastoma Stem Cells
Pharmaceutical Research · 2021
Development of Targetable Multi-Drug Nanoparticles for Glioblastoma Treatment and In Vitro Evaluation in Glioblastoma Stem Cells
bioRxiv (Cold Spring Harbor Laboratory) · 2020
Use of Precision Medicine Molecular Profiling of Baseline Tumor Specimen May Not Benefit Outcomes in Children With Relapsed or Refractory Pediatric Sarcomas
Clinical Pharmacology & Therapeutics · 2016
Erratum: Small-molecule inhibitors targeting the DNA-binding domain of STAT3 suppress tumor growth, metastasis and STAT3 target gene expression in vivo
Oncogene · 2016

Publishes in

Cancer Research×26
bioRxiv (Cold Spring Harbor Laboratory)×8
PMC×6
Figshare×5
Cancers×4

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 11, 2026.

Claim or correct this profile